Benzinga | Aug 24, 2021 04:17PM EDT

Cellect Biotechnology Q2 EPS $(0.004) Up From $(0.007) YoY

Cellect Biotechnology (NASDAQ:APOP) reported quarterly losses of $(0.00) per share. This is a 42.86 percent increase over losses of $(0.01) per share from the same period last year.